Related to Is the Progression of Adult Stem Cell Therapies into the Clinic a Good Sign for Technology?

• Geron’s Setback with Testing Its hESC Therapy in Humans Points to FDA’s Continued Cautionary Stance
  Data from animal studies prompted the clinical hold, which highlights the various kinks yet to be worked out.
  
• Advancing Stem Cell Therapies for Multiple Sclerosis
  UKSCF partners with MS Society to financially support clinical development.
  
• Nanotechnology Enables Precise Cancer Targeting
  While first-generation nanodrugs reduced toxicity, next-gen treatments are being designed to increase efficacy.
  
• Court’s Halt of Federally Backed ESC Research May Impact Economic Growth
  If the injunction sticks, U.S. firms will likely send ESC research jobs abroad.
  
• Japan Disaster Renews Interest in Antiradiation Drug Development
  BARDA's flexibility in dealing with industry is improving investor's confidence in biodefense.
  
• A Clearer Regulatory Pathway for Cell Therapy May Help Improve Investment
  In the U.S. and the U.K., gov’t and foundations play a key funding role as investors try to avoid the risk.
  
• U.S. Stem Cell Companies Find Partners and Revenues Beyond the Water’s Edge
  Firms find it easier to navigate regulatory requirements in Asia as well as Europe.
  
• Will Less SOX2 Lead to Brain Cancer Getting Cold Feet?
  PLK1 level is elevated in glioblastoma multiforme, and its inhibition restricts the growth of brain cancer cells.
  
• Stem Cell Tourism Hardly a Vacation
  Until the scientific evidence for both safety and efficacy is determined, these alternative treatments will be heavily scrutinized.
  
• Tissue Engineering No Easy Cell
  A new paradigm of medicine is taking hold with regenerative medicine at the forefront, but challenges still remain.
  
• Prizes and Quackery Dominate iPS Cell News
  Through ups and downs, the question remains: Do induced pluripotent stem cells have near-term clinical potential?
  
• In Vitro Clinical Trials: Not that Far-Fetched
  Scientists foresee a time when induced pluripotent stem cells could be used to predict patients’ response to a drug.
  
• Bioprinting in 3D
  Scientists are working on extending the principles of 3D printing to constructing organs and tissues using bioprinters.
  
• Targeting Deranged Metabolism to Treat Cancer
  Scientists are investigating how genes controlling metabolism are connected with cancers.
  
• Stem Cell Science Advances
  Find out just how far we’ve come in the field.
  
• Scientists Transplant Functional, Lab-Grown Human Liver into Mouse
  With human iPSC liver buds, researchers make progress in moving regenerative medicine toward the clinic.
  
• Do VSELs Hold Water?
  Very small embryonic-like stem cell research is even supported by the Vatican, but is raising serious questions from some researchers.
  
• Hearing Better Through Chemistry
  Drug or stem cell therapies for hearing loss may replace mechanical devices within a few years.
  
• New Life for Embryonic Stem Cells
  Positive results from new studies show that ESCs still hold much potential for regenerative medicine.
  
• Osiris’ Race to Market an FDA-Approved Stem Cell Product
  Mesenchymal stem cell therapy Prochymal is in Phase III but still has challenges to overcome.